MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S.
A clinical trial on the VIA Disc NP treatment for discogenic back pain has shown impressive results, significantly reducing pain and improving back function. The non-surgical, minimally invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results